TG Therapeutics (TGTX) posted a net profit margin of 13.3%, down from 27.6% a year ago, but remained profitable with strong momentum. Five-year average annual earnings growth reached 48.3%. The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback